Study: Phase II Open-label, Multi-center Study of KIMMTRAK in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma (mUM) with Integrated Circulating Tumor DNA (ctDNA) Biomarker (TARGET-tebe)
Thank you for expressing your interest in a research study and for taking the time to provide your information.
By clicking 'Submit', your information will be shared with the research team. Typically a member of the research team will contact you within 5 to 7 business days.
Please understand that:
Thanks again. Volunteers such as yourself are at the core of our work.